Switzerland· 41983027

Faktu

A cinchocaine product containing policresulenum, cinchocaini hydrochloridum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 5 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC C05AD04

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedFaktuATCC05AD04REGISTER NO.41983027PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Cinchocaine is registered in 5 of 19 countries.

Countries holding a registration under ATC C05AD04 (cinchocaine), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 3 of them publish a price we can compare per daily dose

Cinchocaine · ATC C05AD04

5 / 19 countries

  • Czechiaprice
  • Finlandprice
  • Germany
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
policresulenum, cinchocaini hydrochloridum
Manufacturer
—
Country
Switzerland (CH)
ATC code
C05AD04
ATC class
Cinchocaine
Swissmedic category
B
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680419830271
    60 g
    CHF 25.25

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

41 interactions on record for cinchocaine.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Cinchocaine · interactions on record

41 records

  • 1 severe
  • 40 moderate

Most severe, free to view

  • PrilocaineN01BB04severe
  • MetoclopramideA03FA01moderate
  • SulfamethizoleB05CA04moderate
  • LidocaineC01BB01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cinchocaine in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cinchocaine products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Czechia · Faktu
  • Croatia · Faktu
  • Portugal · Faktu, Hemorapyd
  • Slovenia · Faktu
  • Slovakia · Faktu

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/af03dd50-b2e9-4c7f-bfbb-5b37367f3145
GET /v1/drugs/af03dd50-b2e9-4c7f-bfbb-5b37367f3145?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "policresulenum 50 mg + cinchocaini hydrochloridum 10 mg",
  "valid_from": "1981-03-15",
  "limitations": null,
  "galenic_form": "Salbe mit Disp",
  "therapeutic_area": null,
  "sl_inclusion_date": "1981-03-15",
  "self_retention_pct": 10
}

See everything about cinchocaine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.